CLINUVEL PHARMACEUTICALS LIMITED (CUVL) Net income 2024–2026
CLINUVEL PHARMACEUTICALS LIMITED (CUVL) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$23.2MFY2026 · since FY2024: $23.3M → $23.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $23.2M | +0.2% |
| FY2025 | $23.1M | -1.0% |
| FY2024 | $23.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CUVL financial trends
CUVL RevenueCUVL Net marginCUVL Gross profitCUVL Gross marginCUVL Operating incomeCUVL Operating marginCUVL Operating cash flowCUVL Free cash flowCUVL Capital expendituresCUVL Return on equityCUVL Stock buybacksCUVL Dividends paidCUVL Total assetsCUVL Total liabilitiesCUVL Shareholders’ equityCUVL overview →